JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level

Natalizumab-treated patients have a higher risk of developing progressive multifocal leukoencephalopathy. Exposure to John Cunningham virus (JCV) is a prerequisite for PML (progressive multifocal leukoencephalopathy). To assess JCV exposure in multiple sclerosis patients, we performed a serological...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanzillo, Roberta, Liuzzi, Raffaele, Vallefuoco, Luca, Moccia, Marcello, Amato, Luca, Vacca, Giovanni, Vacchiano, Veria, Portella, Giuseppe, Brescia Morra, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199559/
https://www.ncbi.nlm.nih.gov/pubmed/25328396
http://dx.doi.org/10.2147/TCRM.S63295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199559/
https://www.ncbi.nlm.nih.gov/pubmed/25328396
http://dx.doi.org/10.2147/TCRM.S63295

Ejemplares similares